Correction: Biologics for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-analysis

Affiliations

¹ Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY, 10029-5674, USA. mark.lebwohl@mountsinai.org.
² Hospital Moinhos de Vento, Porto Alegre, Brazil.
³ Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.
⁴ Department of Dermatology, Peking University People's Hospital, Beijing, China.
⁵ Evidinno Outcomes Research Inc., Vancouver, Canada.
⁶ Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA.
⁷ Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.

Published Erratum

Mark G Lebwohl et al. Dermatol Ther (Heidelb). 2025 Oct.

. 2025 Oct;15(10):3069-3070.

doi: 10.1007/s13555-025-01527-7.

¹ Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY, 10029-5674, USA. mark.lebwohl@mountsinai.org.
² Hospital Moinhos de Vento, Porto Alegre, Brazil.
³ Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.
⁴ Department of Dermatology, Peking University People's Hospital, Beijing, China.
⁵ Evidinno Outcomes Research Inc., Vancouver, Canada.
⁶ Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA.
⁷ Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.

No abstract available

Erratum for

Biologics for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-analysis.
Lebwohl MG, Carvalho A, Asahina A, Zhang J, Fazeli MS, Kasireddy E, Serafini P, Ferro T, Gogineni R, Thaçi D. Lebwohl MG, et al. Dermatol Ther (Heidelb). 2025 Jul;15(7):1633-1656. doi: 10.1007/s13555-025-01423-0. Epub 2025 May 6. Dermatol Ther (Heidelb). 2025. PMID: 40329054 Free PMC article. Review.